NCAM1 and neoplasm: In fact, a study by Nitta et al. showed that neutralization of CD56 molecules expressed on NK cells inhibits the cytotoxicity of these lymphocytes only towards target cells that express CD56 (i.e. tumor cell lines of neuroectodermal origin) but not towards CD56-negative leukemic targets61.